-
Behavioural scienceAlcohol and drug use refines
Accidental overdose admissions in New South Wales and later premature death by cause
Among 14,036 people hospitalised for accidental overdose in New South Wales, deaths ran at 3.5 times the expected rate.
Peer-reviewed -
Data, models and systemsForecasts and their record new
Alzheimer's disease model links slower cognitive decline to later institutionalisation
In a memory clinic microsimulation, 30% slower MMSE decline delayed institutional care by 1.1 years, with similar time spent there.
Peer-reviewed -
Data, models and systemsForecasts and their record refines
Ensemble models of expected US mortality were more accurate than single models
Using weekly US deaths for 2008–2024, ensemble models gave more accurate expected mortality, with better coverage, than single models.
Peer-reviewed -
Data, models and systemsWhat linked data reveals refines
Hepatitis C treatment in one US state's Medicaid rose as access restrictions ended
Hepatitis C treatment initiation in one US state's Medicaid rose as restrictions ended, but peaked at 23% for 2020 diagnoses.
Peer-reviewed -
Health todayMental health refines
Suicide mortality in the Americas rose from 2015 to 2021 despite a one-third cut target
The regional age-standardised suicide mortality rate rose by 1·05% a year on average between 2015 and 2021, and only 10 of 33 countries fell fast enough to meet a one-third cut by 2030.
Peer-reviewed -
Data, models and systemsHealth systems and access confirms
Neighbourhood deprivation and excess mortality after clinical risk adjustment in Medicare
Among 4,477,014 Medicare beneficiaries, excess mortality was 0.5 percentage points higher in the most deprived decile than the middle.
Peer-reviewed -
Data, models and systemsForecasts and their record new
People who inject drugs in the US: projected deaths, infections and costs, 2025-2034
A US microsimulation projects 487 249 deaths from injection drug use and $565 billion in healthcare costs over 2025–2034.
Peer-reviewed -
Data, models and systemsValue in health confirms
One-time CKD screening at age 55 in Finland: a lifetime cost-effectiveness model
Modelled one-time CKD screening of Finns aged 55, plus SGLT2i and RAASi treatment, cost €6,478 per quality-adjusted life year.
Peer-reviewed -
Behavioural scienceDiet, exercise and sleep new
GLP-1/GIP use in US adults rose to 12% by 2025, a third via non-traditional access
GLP-1/GIP use rose from 8.2% to 12.0% of US adults in 18 months, led by weight-loss use.
Preprint · not peer-reviewed -
Data, models and systemsValue in health contradicts
Polygenic risk-guided prostate cancer screening was not cost-effective in a UK model
In a UK-calibrated microsimulation, prostate cancer screening guided by polygenic risk scores cost more and was less effective than alternatives.
Peer-reviewed -
Behavioural scienceInfection and pandemics refines
Injection-schedule adherence to long-acting cabotegravir plus rilpivirine in Spain
Among 3280 virologically suppressed adults in Spain, 70.4% received every evaluable injection within ±7 days; 0.7% had suboptimal adherence.
Peer-reviewed -
Health todayDementia refines
Education and dementia: a schooling reform cut incidence and weakened genetic risk
A compulsory schooling reform showed that extra education lowered dementia incidence and weakened the link between genetic risk and dementia.
Peer-reviewed